Wider use of continuous glucose monitoring (CGM), glycemic management during cancer treatment, and individualized dosing of obesity drugs in people with diabetes are just a few of the new topics and ...

Additional recommendation on the use of obesity medications in diabetes patients is provided in the updated guidelines. The American Diabetes Association ® (ADA) has released its latest evidence-based ...

Experts at ADA 2026 say nutrition guidelines must be personalized, culturally responsive, and built on research that reflects the patients they're meant to serve. In a VESALIUS-CV subgroup analysis, ...

The 2026 ADA Standards of Care really further elaborate on the benefits of incretin-based therapies. I can't go through in great detail all of the different roles that incretin-based therapies now ...

"ADA26: T1 and T2 diabetes readouts from Roche, MannKind and Lilly" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

After decades of neglect, malnutrition-related diabetes, or type 5, is finally getting the research, recognition, and ...